IDALIA FERNANDEZ-SLOVES: Open Payments
NPI 1336180629 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,652 in 57 payments from 6 companies in 2025. Trend: 2023 $280 · 2024 $907 · 2025 $6,652
Consulting: $2,640Travel & lodging: $2,101Food & beverage: $1,911
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 34 | $6,025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $237 |
| Madrigal Pharmaceuticals | 3 | $185 |
| Ipsen Biopharmaceuticals, Inc | 1 | $125 |
| ORPHALAN INC | 2 | $49 |
| Veloxis Pharmaceuticals, Inc. | 1 | $31 |
Products named: Livdelzi, XIFAXAN, REZDIFFRA, Vemlidy, IQIRVO, CUVRIOR, ENVARSUS.
Industry payments across NY — which companies pay providers there.
